정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1185 | Recruiting | Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19) | Coronavirus Disease 2019 | Drug: Interferon-Alpha2B Drug: Placebo |
Phase 2 | Pontificia Universidad Catolica de Chile, Altum Pharmaceuticals INC | OTHER | 168 | All | 18 Years | Red de Salud UC Christus, Santiago, RM, Chile |
| 1184 | Recruiting | Inhaled Ivermectin and COVID-19 | COVID-19 | Drug: Ivermectin Powder | Phase 3 | Mansoura University | OTHER | 80 | All | 18 Years ~ 80 Years | Mansoura Faculty of Medicine, Mansoura, Dakahlyia, Egypt |
| 1183 | Terminated | Inhaled Nitric Oxide for Preventing Progression in COVID-19 | COVID-19 | Drug: Nitric Oxide | Phase 2 | Tufts Medical Center, Bellerophon | OTHER | 10 | All | 18 Years ~ 85 Years | Tufts Medical Center, Boston, Massachusetts, United States |
| 1182 | Recruiting | Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19 | Dyspnea | Drug: ZYESAMI™ (aviptadil acetate) Drug: Placebo Device: Nebulized administration of ZYESAMI™ or Placebo |
Phase 3 | NeuroRx, Inc. | INDUSTRY | 144 | All | 18 Years ~ 85 Years | St. Jude Medical Center, Fullerton, California, United States University of California - Irvine, Irvine, California, United States University of Miami Leonard M. Miller School of Medicine (UMMSM), Miami, Florida, United States Advent Health Research Institute, Orlando, Florida, United States Northwestern Medical Group, Winfield, Illinois, United States University of Louisville Hospital, Louisville, Kentucky, United States Great Plains Health, North Platte, Nebraska, United States Holy Name Medical Center, Teaneck, New Jersey, United States Kettering Health Network, Kettering, Ohio, United States Doylestown Hospital, Doylestown, Pennsylvania, United States University of Texas San Antonio Medical Arts and Research Center, San Antonio, Texas, United States |
| 1181 | Withdrawn | iNOPulse for COVID-19 | Hypoxemic Respiratory Failure | Drug: Inhaled nitric oxide (iNO) Drug: Nitrogen gas Drug: Oxygen gas |
Phase 2 | Roger Alvarez, Bellerophon Therapeutics | OTHER | 0 | All | 18 Years | University of Miami Hospitals & Clinics, Miami, Florida, United States |
| 1180 | Not yet recruiting | In-patient COVID-19 Study of Intranasal Foralumab | COVID-19 Respiratory Infection | Drug: Foralumab Other: Placebo |
Phase 2 | Tiziana Life Sciences, PLC | INDUSTRY | 80 | All | 18 Years | |
| 1179 | Completed | Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC) | SARS (Severe Acute Respiratory Syndrome) | Biological: Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG) Other: Placebo Drug: Remdesivir |
Phase 3 | University of Minnesota, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) | OTHER | 593 | All | 18 Years | Penrose Hospital, Colorado Springs, Colorado, United States St. Francis Health Services, Colorado Springs, Colorado, United States St. Anthony Hospital, Lakewood, Colorado, United States Saint Anthony North Health Campus, Westminster, Colorado, United States Washington VA Medical Center, Washington, District of Columbia, United States Redmond Regional Medical Center, Rome, Georgia, United States National Institutes of Health Clinical Center, Bethesda, Maryland, United States University of Massachusetts, Worcester, Massachusetts, United States Hennepin Healthcare Research Institute/HCMC, Minneapolis, Minnesota, United States University of Missouri, Columbia, Missouri, United States Cox Medical Centers, Springfield, Missouri, United States FirstHealth Moore Regional Hospital, Pinehurst, North Carolina, United States Ohio Health Research Institute, Columbus, Ohio, United States Hendrick Medical Center, Abilene, Texas, United States CHRISTUS Spohn Shoreline Hospital, Corpus Christi, Texas, United States University of Texas Southwestern Medical Center, Dallas, Texas, United States CJW Chippenham Medical Center, Richmond, Virginia, United States Henrico Doctors' Hospital (HCA), Richmond, Virginia, United States Aarhus Universitetshospital, Skejby, Aarhus, Denmark Bispebjerg Hospital, Copenhagen, Denmark CHIP, Department of Infectious Diseases, Section 2100, Copenhagen, Denmark Herlev-Gentofte Hospital, Hellerup, Denmark Nordsjællands Hospital, Hillerød, Hillerød, Denmark Hvidovre University Hospital, Department of Infectious Diseases, Hvidovre, Denmark Kolding Sygehus, Kolding, Denmark Odense University Hospital, Odense, Denmark Democritus University of Thrace, Alexandroupoli, Thrace, Greece 3rd Dept of Medicine, Medical School, NKUA, Athens, Greece 1st Respiratory Medicine Dept, Athens University Medical School, Athens, Greece Attikon University General Hospital, Athens, Greece Dept. of Critical Care & Pulmonary Medicine, Evangelismos General Hospital, Athens, Greece NCGM, Tokyo, Japan Fujita Health University Hospital, Toyoake, Japan Institute of Human Virology-Nigeria (IHVN), Abuja, Nigeria Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain Hospital del Mar, Barcelona, Spain Hospital Clinic de Barcelona, Barcelona, Spain Royal Free Hospital, London, United Kingdom |
